Johns Hopkins enhances early detection methods for Alzheimer's

Research at Johns Hopkins, funded by the National Institutes of Health, is advancing early detection and treatment of Alzheimer's disease. Led by Michael I. Miller, the study uses enhanced MRI and patient data to identify brain changes before symptoms appear. Miller's team is exploring gene expression changes linked to Alzheimer's, aiming for personalized treatments. Their work builds on previous findings that MRI can detect brain changes over a decade before symptoms emerge. The research emphasizes collaboration among scientists and clinicians to improve understanding and treatment of neurological diseases. A new brain image database, MRICloud, supports further research in this area.